Cargando…
Amyloid Beta-Related Alterations to Glutamate Signaling Dynamics During Alzheimer’s Disease Progression
Alzheimer’s disease (AD) ranks sixth on the Centers for Disease Control and Prevention Top 10 Leading Causes of Death list for 2016, and the Alzheimer’s Association attributes 60% to 80% of dementia cases as AD related. AD pathology hallmarks include accumulation of senile plaques and neurofibrillar...
Autores principales: | Findley, Caleigh A., Bartke, Andrzej, Hascup, Kevin N., Hascup, Erin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582288/ https://www.ncbi.nlm.nih.gov/pubmed/31213067 http://dx.doi.org/10.1177/1759091419855541 |
Ejemplares similares
-
Hippocampal alterations in glutamatergic signaling during amyloid progression in AβPP/PS1 mice
por: Hascup, Kevin N., et al.
Publicado: (2020) -
Friend or Foe? Defining the Role of Glutamate in Aging and Alzheimer’s Disease
por: Cox, MaKayla F., et al.
Publicado: (2022) -
Alterations of Calcium Channels in a Mouse Model of Huntington’s Disease and Neuroprotection by Blockage of Ca(V)1 Channels
por: Miranda, Artur S., et al.
Publicado: (2019) -
Prodromal Glutamatergic Modulation with Riluzole Impacts Glucose Homeostasis and Spatial Cognition in Alzheimer’s Disease Mice
por: Findley, Caleigh A., et al.
Publicado: (2023) -
Amyloid-β(42) stimulated hippocampal lactate release is coupled to glutamate uptake
por: Hascup, Erin R., et al.
Publicado: (2022)